• Programme
  • In vitro
    demonstration
  • Pre-clinical
    trials
  • Safety
    trials
  • Follow-on
    trials
  • Market
  • STAGE*
  • 1
  • 2
  • 3
  • 4
  • 5

  • Malaria
  •  
  •  
  •  
  •  
  •  

  • Sepsis
  •  
  •  
  •  
  •  
  •  

  • Leukaemia
  •  
  •  
  •  
  •  
  •  

*Programme Stage Key

1 - In vitro demonstration /  2 - Pre-clinical trials /  3 - Safety trials /  4 - Follow-on trials / 5 - Market

Latest News

A Great Start to 2020

A Great Start to 2020
January 16, 2020

If you missed it, before Christmas, we announced that Dr George Frodsham, CEO and founder of innovative MedTech company, MediSieve, had been selected as one of MIT Technology Review’s Innovators Under 35 Europe 2019.
MediSieve Founder Honoured as MIT Technology Review’s Innovator Under 35

MediSieve Founder Honoured as MIT Technology Review’s Innovator Under 35
December 19, 2019

Dr George Frodsham, CEO and founder of innovative MedTech company, MediSieve, has been selected as one of MIT Technology Review’s Innovators Under 35 Europe 2019.
Copyright 2020 by MediSieve. Company number 8983823 registered in England and Wales. Registered address: 48 Chancery Lane, London, WC2A 1JF.
Terms of use | Privacy Policy |